Home About us Contact | |||
Postnatal Growth Rate (postnatal + growth_rate)
Selected AbstractsEmbryo growth rates in birds and mammalsFUNCTIONAL ECOLOGY, Issue 3 2010Robert E. Ricklefs Summary 1.,Embryo mass growth curves of 36 species of bird and 18 species of mammal were fitted by sigmoidal Gompertz functions, in which k (days,1) describes the rate at which the embryo approaches an asymptotic mass A (g). 2.,The parameters of the Gompertz function were uncorrelated with parameters of power functions fitted to the same growth data, indicating that the two models describe different aspects of growth. 3.,Asymptotes of the Gompertz functions for embryonic growth averaged 2·5 times neonate size, but were well below adult mass. Thus, the pre- and postnatal phases of growth are distinct and have different target sizes. 4.,Embryo growth rate (k) decreases as the ,1/4 power of neonate size; values for mammals were 63% of those of birds, on average. 5.,Embryo growth rate can be predicted solely by the length of the incubation or gestation period, regardless of the size of the neonate, with the same relationship for birds and mammals. 6.,Postnatal growth rate (kG) scales linearly with embryonic growth rate (k), but is nearly five- times more rapid, on average, in birds than in mammals. kG and k have similar magnitude in birds, but kG is relatively much slower than k in mammals. 7.,Rate of actuarial senescence , (year,1), measured by the increase in mortality rate with age, is positively related to the rate of embryo growth in both birds and mammals, but is higher in the latter. Moreover, rate of ageing in birds is uniquely related to embryo growth while that in mammals is uniquely related to postnatal growth rate. Thus, development and ageing appear to be differently connected in birds and mammals, although the basis for these relationships is not known. [source] Postnatal growth and reproductive biology of Rhinolophus hipposideros (Chiroptera: Rhinolophidae)JOURNAL OF ZOOLOGY, Issue 3 2004Guido Reiter Abstract The timing of birth and postnatal growth in lesser horseshoe bats Rhinolophus hipposideros were studied during 2000 and 2001 at three maternity roosts located in the provinces of Carinthia and Salzburg, Austria. Postnatal growth curves for length of forearm and body mass were determined separately for the different colonies and years. Cooler weather during June 2001 coincided with a median birth date that was 8 days later than in 2000, whilst the difference between colonies was 4 and 5 days, respectively, for the pooled data of both years. Cool temperatures in June also coincided with a longer duration of the parturition period. Postnatal growth rates were higher than in most other bat species but differences between years and colonies were considerable. These differences may be attributed to the ambient roost temperatures, whereby the young of two cooler roosts showed significantly reduced growth rate during 8 days of cool weather in 2000. Moreover, later born and therefore smaller pups were more strongly affected by low temperatures than earlier born and larger ones. The mean length of forearm of young lesser horseshoe bats at the beginning of September equalled that of adult bats, whilst their body mass was still lower. Non-volant juveniles did not cluster following the nightly emergence of adult females, and a preferred location within the roosts could not be identified. High and very low roost temperatures, however, did have an influence on the location of non-volant young in the colonies. [source] Embryo growth rates in birds and mammalsFUNCTIONAL ECOLOGY, Issue 3 2010Robert E. Ricklefs Summary 1.,Embryo mass growth curves of 36 species of bird and 18 species of mammal were fitted by sigmoidal Gompertz functions, in which k (days,1) describes the rate at which the embryo approaches an asymptotic mass A (g). 2.,The parameters of the Gompertz function were uncorrelated with parameters of power functions fitted to the same growth data, indicating that the two models describe different aspects of growth. 3.,Asymptotes of the Gompertz functions for embryonic growth averaged 2·5 times neonate size, but were well below adult mass. Thus, the pre- and postnatal phases of growth are distinct and have different target sizes. 4.,Embryo growth rate (k) decreases as the ,1/4 power of neonate size; values for mammals were 63% of those of birds, on average. 5.,Embryo growth rate can be predicted solely by the length of the incubation or gestation period, regardless of the size of the neonate, with the same relationship for birds and mammals. 6.,Postnatal growth rate (kG) scales linearly with embryonic growth rate (k), but is nearly five- times more rapid, on average, in birds than in mammals. kG and k have similar magnitude in birds, but kG is relatively much slower than k in mammals. 7.,Rate of actuarial senescence , (year,1), measured by the increase in mortality rate with age, is positively related to the rate of embryo growth in both birds and mammals, but is higher in the latter. Moreover, rate of ageing in birds is uniquely related to embryo growth while that in mammals is uniquely related to postnatal growth rate. Thus, development and ageing appear to be differently connected in birds and mammals, although the basis for these relationships is not known. [source] Pathology is alleviated by doxycycline in a laminin-,2,null model of congenital muscular dystrophyANNALS OF NEUROLOGY, Issue 1 2009Mahasweta Girgenrath PhD Objective Congenital muscular dystrophy type 1A is an autosomal recessive disease that is caused by loss-of-function mutations in the laminin-,2 gene, and results in motor nerve and skeletal muscle dysfunction. In a previous study, we used genetic modifications to show that inappropriate induction of apoptosis was a significant contributor to pathogenesis in a laminin-,2,deficient mouse model of congenital muscular dystrophy type 1A. To identify a possible pharmacological therapy for laminin-,2 deficiency, we designed this study to determine whether treatment with minocycline or doxycycline, which are tetracycline derivatives reported to have antiapoptotic effects in mammals, would significantly increase lifespan and improve neuromuscular function in laminin-,2,deficient mice. Methods Mice that were homozygous for a targeted, inactivating mutation of the laminin-,2 gene were placed into control, minocycline-treated, or doxycycline-treated groups. Drug treatment began within 2 weeks of birth, and the progression of disease was followed over time using behavioral, growth, histological, and molecular assays. Results We found that treatment with either minocycline or doxycycline increased the median lifespan of laminin-,2,null mice from approximately 32 days to approximately 70 days. Furthermore, doxycycline improved postnatal growth rate and delayed the onset of hind-limb paralysis. Doxycycline-treated laminin-,2,deficient muscles had increased Akt phosphorylation, decreased inflammation, and decreased levels of Bax protein, terminal deoxynucleotidyltransferase,mediated dUTP nick end labeling,positive myonuclei, and activated caspase-3. Interpretation Doxycycline or other drugs with similar functional profiles may be a possible route to improving neuromuscular dysfunction caused by laminin-,2-deficiency. Ann Neurol 2008 [source] Iron balance and iron nutrition in infancyACTA PAEDIATRICA, Issue 2003G Faldella At birth, the total body iron content is approximately 75 mg/kg, twice that of an adult man in relation to weight. During the first 6 mo of life, total iron body content increases slightly and exclusive breastfeeding is sufficient to maintain an optimal iron balance. Thereafter, iron body content substantially increases and the infant becomes critically dependent on dietary iron, provided by complementary foods. Numerous factors may contribute to nutritional iron deficiency in infancy, the most important being low body iron content at birth, blood loss, high postnatal growth rate, and a low amount and/or bioavailability of dietary iron. We have documented that the prevalence of iron deficiency declined in Italy as iron nutrition improved and that early feeding on fresh cow's milk is the single most important determinant of iron deficiency in infancy. Healthy full-term infants should maintain optimal iron balance by consuming a good diet, which can be summarized as follows: breastfeeding should be continued exclusively for at least 5 mo and then together with complementary foods containing highly bioavailable iron; infants who are not breastfed or are partially breastfed should receive an iron-fortified formula, containing between 4.0 and 8.0mg/L iron, from birth to 12 mo of age; fresh cow's milk should be avoided before 12 mo of age. [source] |